Helping two global pharma companies uncover a winning position for launch of a new drug
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Escalent has done some great work for me and my team over the past years...great moderating skills and research reporting.
Two global pharma companies joined forces to launch a new prescription medicine for treatment of a mental health condition. The clients understood how competitive the landscape is for mental health treatment products and needed Escalent’s help to identify market needs for four audiences: patients, caregivers, psychiatrists and primary care doctors. They also needed help developing, assessing and finalizing the strongest position for this new treatment.
Escalent facilitated in-person workshops with multidisciplinary client teams from both companies. We then conducted several rounds of qualitative research in and outside the US. We used pre-research activities—patient chart pulls for doctors and photo stories for patients—as well as storytelling to gain a comprehensive understanding of the impact of mental conditions. Then we overlaid the unmet needs of the market with the new treatment’s benefits and tested four market insights. By blending this qualitative research with the clients’ previous quantitative research, we identified one very strong insight that was used to develop and test the elements of the product positioning story.
We successfully identified one specific need and crafted a meaningful and durable positioning recommendation to senior management. The clients were extremely pleased with how well the positioning was constructed—it was believable, important and achievable. The clients launched the product using our recommendation as the backbone of the positioning and continue to use the positioning two years later. Global sales are approaching half a billion dollars and the clients’ brand strength has improved year over year.
In a recent discussion amongst industry peers, we examined why trust is so crucial, how it can be measured, and the challenges and opportunities it presents in the pharma and healthcare industries.
As asset managers increasingly focus on promoting a unified corporate brand, new data from Cogent Syndicated reveal an opportunity for messaging to help firms define their unique value proposition in the current US advisor market.
While the term “Brand Authenticity” buzzes across industries, organizations need to know who they truly are to live up to that ideal to build brand trust and attract loyal customers. Escalent's Rob Darrow shares three brand authenticity lessons to help you bridge the gap between your brand's ideal and actual state.
Explore the future of school buses, strip chassis and RVs in part two of our miniblog series, with expert insights and four recommendations to stay competitive in the classes 6 and 7 commercial vehicle market
Our auto experts provide valuable insights and data on the fundamental forces shaping the classes 6 and 7 commercial vehicle market and how OEMs, body companies and suppliers can meet this market’s future needs
Normative databases are useful in market research, but like any tool, come with their own set of limitations that are often not fully acknowledged or recognized. Here’s what to look out for.
A new report from Cogent Syndicated reveals several market dynamics occurring simultaneously where trust, technology and human expertise converge. Read on to learn how wealth managers can succeed during this critical intersection and strengthen brand equity among key segments of investors.
Sonia Davis dives into data from our new report to reveal that DC advisors are warming up to emerging AI’s potential and talks about advisors' heightened fear of cybersecurity issues, echoing the fears reported by plan sponsors and their participants.
A new report from Cogent Syndicated reveals opportunities for community banks and credit unions to help future inheritors navigate the complexities of the estate planning process and provide guidance beyond the standard checking and savings accounts.
